GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Russian bomb factory acquiring Siemens technology amid sanctions - Global Banking & Finance Review
Image illustrating the Biysk Oleum Factory's acquisition of Siemens equipment via intermediaries, highlighting the circumvention of Western sanctions. This reflects ongoing military production efforts in Russia.
Finance

Rentokil shares slump 17% on slower North America growth

Published by Global Banking & Finance Review

Posted on July 30, 2026

2 min read

· Last updated: July 30, 2026

Add as preferred source on Google

Rentokil shares slump 18% on slower North America growth

Rentokil's Second-Quarter Performance and Market Reactions

July 30 (Reuters) - British pest control firm Rentokil on Thursday said second-quarter sales growth in North America slowed sequentially and it had more to do to address its underperformance, sending its shares tumbling almost 18% in early trading.

Company Statements and Strategic Initiatives

Here are some more details:

Leadership Commentary

• "We are not delivering on our growth potential in many of the markets we operate in, nor adequately benefiting from our scale," Chief Executive Mike Duffy said.

Market Challenges

• Inflationary pressures, high interest rates and weak consumer sentiment linked to the Iran war have led Rentokil's customers to scale back spending on routine services.

Strategic Responses

• Last year, Rentokil introduced smaller, strategically-placed service hubs, higher digital marketing and door-to-door services as part of its strategy to tackle weakness in North America.

Financial Results and Outlook

Revenue Growth Figures

• The company reported organic revenue growth of 3.6% in its largest market in the three months to June 30, down from 3.9% in the first quarter.

Future Expectations

• "Looking forward, we have seen some weakness in North America Residential lead flow towards the end of the second quarter and into July," Duffy said.

• Still, Rentokil said full-year profit would meet market expectations.

Analyst Reactions

• "Given the comments on lead flow exiting the quarter, we expect confidence in (full year) outlook to reduce," J.P. Morgan analysts said in a note.

Industry Comparison and Share Performance

Peer Performance

• Rentokil's results echoed troubles at U.S. rival Rollins, which last week fell short of Wall Street estimates for its second quarter.

Share Price Impact

• Shares of the London-listed company were down 17.7% at £3.65 as of 0810 GMT, on track for their worst day since September 2024 if losses hold.

(Reporting by Neeshita Beura in Bengaluru; Editing by Janane Venkatraman and Nivedita Bhattacharjee)

Key Takeaways

  • North American organic growth decelerated sequentially (3.6% vs 3.9% in Q1), triggering a sharp 17% stock drop.
  • Rentokil’s largest market continues to underperform expectations, underscoring challenges in its North America turnaround strategy. Goldman Sachs sees potential recovery ahead, having recently upgraded the stock on execution improvements. (investing.com)
  • By comparison, industry peer Rollins delivered stronger organic growth (~5.7%) in Q2 of 2026, highlighting Rentokil’s relative underperformance in North America. (rollins.com)

References

Frequently Asked Questions

Why did Rentokil shares fall by 17%?
Rentokil shares dropped 17% due to slower second-quarter sales growth in North America and ongoing underperformance concerns.
What was Rentokil's Q2 organic revenue growth in North America?
Rentokil reported 3.6% organic revenue growth in North America for the second quarter.
How did Rentokil's Q2 growth compare to the previous quarter?
Q2 growth slowed to 3.6% compared to 3.9% in the first quarter.
What actions is Rentokil planning to address its performance?
The company acknowledged more work is needed to address its underperformance in North America.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category